Results 61 - 70 of 218 : Previous 3 4 5 6 7 8 9 10 11 Next
There’s not much to complain about with the company’s second-quarter numbers.
Foolish Forecast: Weighing Elan's Risks and Rewards
Views you can use to get clues on tomorrow’s news.
Dr. Reddy's grows the top line, but it still has some work to do.
Thursday's Biggest Stock Stars
Yesterday's market is today's road map.
More Group Therapy From Generics
The Teva deal for Barr shows consolidation is still underway in the industry.
Stocks hitting fresh highs can either signal that a stock is on its way to greatness or that it has run its course. Even with the risk of the latter, searching for these outperformers can reveal companies that are doing something right, much to their investors' delight.
J&J's Lesson to Investors: Diversify!
J&J gives investors something to cheer about.
Teva Gets a Taste of Its Own Medicine
Drug companies attack the generic-drug makers' patents.
Biotech Investors' Dream Stocks
Make finding the best biotech stocks a reality.
Are its plans for an end-around to block competition coming to a close?
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK